{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:59:57Z","timestamp":1790866797212,"version":"4.1.0"},"reference-count":106,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2408085MH192"],"award-info":[{"award-number":["2408085MH192"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.1080\/13543776.2026.2710223","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:48:18Z","timestamp":1785160098000},"page":"893-909","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Zhiwei","family":"Meng","sequence":"first","affiliation":[{"name":"Hefei University of Technology","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[{"name":"Hefei University of Technology","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Yao","sequence":"additional","affiliation":[{"name":"Hefei University of Technology","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[{"name":"Hefei University of Technology","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouling","family":"Xie","sequence":"additional","affiliation":[{"name":"Hefei University of Technology","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2014.12.025"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09523-9"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010132"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000163262.83456.6d"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00462"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14213"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.05.002"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00963"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c02141"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-22-0149"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.04.012"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110155"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa016"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr0307143"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3570593"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2020.1780210"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2005.09.017"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.16.11964"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311143"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.11.031"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-68510-2"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00172a022"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi9818772"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2396"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(90)90020-V"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2017.12.022"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209264200"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.03.027"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.07.002"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/29.3.513"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01719-0"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi049541h"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218057"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2016.05.029"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14191562"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3892\/br.2022.1536"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.8.5425"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2019.12.009"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-015-9547-7"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102660"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2872607"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-024-10421-x"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00941-0"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-011-9294-3"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03655-4"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2022.102676"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2026.110800"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1067-4"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14574"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3080559"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.266981"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115548"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115418"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00285"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.507756"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1039\/c7md00268h"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115723"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128010"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm3007245"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm4001538"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.07.053"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm1009988"},{"key":"e_1_3_4_67_1","unstructured":"Anna-Karin T AstraZeneca AB. Preparation of 2-thioxanthines as myeloperoxidase (MPO) inhibitors. WO2007142576. 2007."},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv184"},{"key":"e_1_3_4_69_1","unstructured":"AstraZeneca Websites. AZD5904. [cited 2026 Apr 30]. Available from: https:\/\/openinnovation.astrazeneca.com\/preclinical-research\/preclinical-molecules\/azd59041.html"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa328"},{"key":"e_1_3_4_71_1","unstructured":"Ugolini S Roger A. Use of myeloperoxidase (MPO) inhibitors for promoting CD8+ T cell responses. WO2025190901. 2018. Institut National de la Sante et de la recherche Medicale."},{"key":"e_1_3_4_72_1","unstructured":"AstraZeneca Websites. Our pipeline. [cited 2026 Apr 30]. Available from: https:\/\/www.astrazeneca.com\/our-therapy-areas\/pipeline.html"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.074476"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2017.1353163"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00002a018"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02046-4"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi702016q"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.02.006"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115470"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000084"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00813"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04926-x"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.115083"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138528"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00721"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c07555"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202504351"},{"key":"e_1_3_4_88_1","unstructured":"Dubowchik G Lundquist J Theodore I et al. Biohaven Therapeutics Ltd. USA. Preparation of pyrrolopyrimidine prodrugs of myeloperoxidase inhibitors for the treatment of myeloperoxidase-mediated diseases. WO2021072140. 2021."},{"key":"e_1_3_4_89_1","unstructured":"Song Y Yu L Li M et al. Preparation of 2-thio-2 3-dihydropyrimidin-4-one derivatives pharmaceutical compositions and use thereof. CN115403584. 2022."},{"key":"e_1_3_4_90_1","unstructured":"Lai Y Wang Y Xiao Y et al. Preparation of pyrrolopyrimidine derivatives as MPO inhibitor. CN116514816. Shenzhen Salubris Pharmaceuticals Co. Ltd. China; 2023."},{"key":"e_1_3_4_91_1","unstructured":"Inghardt T Lindstedt E Jurva U et al. Preparation of 2-thioxo-1 2 3 5-tetrahydro-4H-pyrrolo[3 2-d]pyrimidin-4-one derivatives as myeloperoxidase inhibitors. WO2024038131. 2023."},{"key":"e_1_3_4_92_1","unstructured":"Putra OD Inghardt TB AstraZeneca AB. 2-thioxo-1-((2-((2R 4S)-4-(trifluoromethyl)piperidin-2-yl)pyridin-3-yl)methyl)-1 2 3 5-tetrahydro-4H-pyrrolo[3 2-d]pyrimidin-4-one as myeloperoxidase inhibitor and its dihydrate preparation pharmaceutical compositions and use in the treatment of diseases. WO2025172474. 2025."},{"key":"e_1_3_4_93_1","unstructured":"Lai Y Wang B Yue X. Pyrrolo[3 2-d]pyrimidin-4-one derivative and preparation method and application as myeloperoxidase (MPO) inhibitor for treating cardiovascular diseases. WO2024120457. Shenzhen Salubris Pharmaceuticals Co. Ltd. China; 2024."},{"key":"e_1_3_4_94_1","unstructured":"Buson A Findlay AD Turner CI et al. Syntara limited. Australia. Dual inhibitors of amine oxidases and peroxidases and uses thereof. WO2025107036. 2025."},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58454-6"},{"key":"e_1_3_4_96_1","unstructured":"Wang X Yuan Y Dong C. Leping Kangxin Pharmaceutical and Chemical Co. Ltd. China. Pyrazole compounds as myeloperoxidase inhibitors for treating cardiovascular diseases. CN121378265. 2026."},{"key":"e_1_3_4_97_1","unstructured":"Rosales H Martha C Padilla M. Microwave-assisted process for obtaining derivatives of (Z)-2-hydroxycinnamic acid and its use as antioxidants and myeloperoxidase inhibitors. MX2019009330. Instituto Politecnico Nacional. 2021."},{"key":"e_1_3_4_98_1","unstructured":"Wang X Yu J. Rui jin Hospital Affiliated to the Shanghai jiao tong University Medical School. China. Preparation of quinazolinyl guanidine compound as MPO inhibitor and its application in preparation of drugs for preventing or treating hypertrophic scars and keloid. CN116789608. 2023."},{"key":"e_1_3_4_99_1","unstructured":"Rautou PE Boulanger-Robert C Poisson J. Use of myeloperoxidase inhibitors for the treatment of cardiovascular diseases in patients suffering from myeloproliferative neoplasms. WO2021013942. INSERM (Institut National de la Sante et de la Recherche Medicale) France; 2021."},{"key":"e_1_3_4_100_1","unstructured":"Cheng L Chen Y Shen Y et al. Zhongshan Hospital Fudan University. China. Application of myeloperoxidase inhibitor in preparing cardioprotective medicine. CN116236486. 2023."},{"key":"e_1_3_4_101_1","unstructured":"Kong L Du G Pan Z et al. Institute of Materia Medica Chinese Academy of Medical Sciences. China. Application of myeloperoxidase inhibitor 4-amino-1-benzylpiperidine in preparing drugs for prevention and\/or treatment of neuroinflammation. CN118892483. 2023."},{"key":"e_1_3_4_102_1","unstructured":"Guo C Wang Z Chen X. China Pharmaceutical University. China. Application of daurisoline in preparing myeloperoxidase inhibitor and medicine for treating acute lung injury. CN119632984. 2025."},{"key":"e_1_3_4_103_1","unstructured":"Krishna NK Cunnion KJ Thienel U. Realta life Sciences inc. USA. Solubility-improved classical\/lectin signal pathway myeloperoxidase activity and NETosis-inhibitory peptides for preventing treating and\/or mitigating side effect or toxicity of checkpoint inhibitors such as intestinal necrosis. WO20222.56304 2022."},{"key":"e_1_3_4_104_1","unstructured":"Cai B Pan J Sun H et al. Preparation method of tuna antioxidant peptide for inhibiting myeloperoxidase (MPO) and application thereof in preparing food functional nutritional product or health product. CN114149490. South China Sea Institute of Oceanology Chinese Academy of Sciences China. 2022."},{"key":"e_1_3_4_105_1","unstructured":"Li J Zhao Y Guo Z et al. Rabbit monoclonal antibody directed against human MPO protein and its application in preparing human MPO protein immunodetection reagents and\/or kits. CN116836289. Wuhan ABclonal Biotechnology Co. Ltd. China; 2022."},{"key":"e_1_3_4_106_1","unstructured":"Tao H Yuan Y Liu Y et al. Method for preparing nanoparticles with dual nets inhibition function and products thereof. CN120859952. PLA Army Medical University China; 2025."},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1157"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019182492"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2710223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2026.2710223","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2710223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:39:33Z","timestamp":1790865573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2710223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,3]]}},"alternative-id":["10.1080\/13543776.2026.2710223"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2710223","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}